Federal Register · Regulatory notice
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
A Notice notice explicitly mentions the company. Read the cited text for its role.
Follow CRNX- Became public
- Sep 17, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 8:48 AM EST
Why this is connected
The source explicitly mentions Crinetics Pharmaceuticals, Inc.. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
......... G ARX Parent Holdings, LP; Flexpoint Fund IV-A, L.P.; ARX Parent Holdings, LP. 20261805.......................... G BCPE (E) Nikolaus Co- Invest, SCSp; Ferdinand Porsche Familien- Privatstiftung; BCPE (E) Nikolaus Co-Invest, SCSp. 20261806.......................... G Triton Fund 6 SCSp; Carlyle Europe Partners V, S.C.Sp.; Triton Fund 6 SCSp. 20261807.......................... G Charles W. Ergen; Innovate Corp.; Charles W. Ergen. 20261810.......................... G Churchill Capital Corp XI; Agility Robotics, Inc.; Churchill Capital Corp XI. 20261813.......................... G Versant Media Group, Inc.; Bruin Sports Capital Holdings, LLC; Versant Media Group, Inc. 20261814.......................... G The Resolute Fund VI, L.P.; Luna Innovations Incorporated; The Resolute Fund VI, L.P. 20261815.......................... G Adobe Inc.; Eric Yang; Adobe Inc. 20261822.......................... G Gerald Simonson; Arcline Double Eagle Master Fund LP; Gerald Simonson. 20261823.......................... G SLG SPAC Fund LLC; ZincFive, Inc.; SLG SPAC Fund LLC. 20261834.......................... G Biogen Inc.; RayThera, Inc.; Biogen Inc. ------------------------------------------------------------------------ 08/04/2026 ------------------------------------------------------------------------ 20261830.......................... G Zymeworks Inc.; Theravance Biopharma, Inc.; Zymewor
Congressional trading in CRNX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 4, 2026$15K–$50K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold Crinetics Pharmaceuticals CRNX
$15K–$50K · Traded Jul 30, 2026 · disclosed Sep 4, 2026
- Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Crinetics Pharmaceuticals CRNX
$1K–$15K · Traded Mar 3, 2026 · disclosed Apr 7, 2026
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Crinetics Pharmaceuticals CRNX
$1K–$15K · Traded Apr 17, 2025 · disclosed May 6, 2025
- Apr 10, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Crinetics Pharmaceuticals CRNX
$1K–$15K · Traded Mar 19, 2025 · disclosed Apr 10, 2025 · Joint
- Feb 11, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Crinetics Pharmaceuticals CRNX
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Oct 3, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Crinetics Pharmaceuticals CRNX
$1K–$15K · Traded Sep 25, 2024 · disclosed Oct 3, 2024 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.